You have 9 free searches left this month | for more free features.

Condition

Acute Myeloid Leukemia (1)

Chronic Myelomonocytic Leukemia (1)

Healthy Volunteers (1)

Myelodysplastic Syndromes (1)

SARS-CoV-2 Infection (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Rhizen Pharmaceuticals SA (3)

Collaborator

Incozen Therapeutics Pvt Ltd (1)

Intervention

rp7214 (2)

placebo (1)

placebo + standard of care (soc) (1)

rp7214 + standard of care (soc) (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

RP7214

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

MDS, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia Trial (RP7214)

Not yet recruiting

Myelodysplastic Syndromes
+2 more

RP7214

(no location specified)

Aug 17, 2022

SARS-CoV-2 Infection Trial in India (RP7214 + Standard of care (SOC), Placebo + Standard of care (SOC))

Completed

SARS-CoV-2 Infection

RP7214 + Standard of care (SOC)
Placebo + Standard of care (SOC)

Bangalore, India
+15 more

Apr 20, 2022

Healthy Volunteers Trial in Las Vegas, Fargo (RP7214, Placebo)

Completed

Healthy Volunteers

RP7214
Placebo

Las Vegas, Nevada
+1 more

Aug 17, 2021